Table 2.
Comparison of opioid consummation, PCA compression, and postoperative recovery
| Characteristic variable | CON group | TLIP group | ESP group | F | P value | P for ESP and TLIP |
|---|---|---|---|---|---|---|
| Sufentanil at OR | 42.85 ± 7.84 | 27.82 ± 3.88 | 28.72 ± 3.99 | 233.376 | < 0.001 | 0.249 |
| Remifentanil | 1233 ± 359.04 | 329.62 ± 365.73 | 359.18 ± 410.81 | 186.078 | < 0.001 | 0.58 |
| Sufentanil in PCA | 192.38 ± 31.34 | 163.38 ± 25.06 | 126.38 ± 18.86 | 188.385 | < 0.001 | < 0.001 |
| PCA compressions (1–24 h) | 6.28 ± 0.69 | 3.9 ± 0.67 | 3.86 ± 0.58 | 458.725 | < 0.001 | 0.684 |
| PCA compressions (24–48 h) | 4.78 ± 0.6 | 3.28 ± 0.78 | 2.69 ± 0.8 | 222.087 | < 0.001 | < 0.001 |
| Remedial analgesic administration | 10.785 | 0.005 | < 0.05 | |||
| No | 71 (69.6) | 83 (83) | 90 (88.2) | |||
| Yes | 31 (30.4) | 17 (15) | 12 (11.8) | |||
| Hospital stay (days) | 5.56 ± 0.57 | 5.19 ± 0.42 | 5.17 ± 0.4 | 22.214 | < 0.001 | 0.725 |
OR operation room, PCA patient-controlled analgesia